A carregar...
Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa
BACKGROUND: Methods to improve the clinical efficacy of currently available antibiotics against multidrug resistant bacteria in cystic fibrosis (CF) chronic rhinosinusitis (CRS) are greatly needed. Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, was recently identified...
Na minha lista:
| Publicado no: | Am J Rhinol Allergy |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728449/ https://ncbi.nlm.nih.gov/pubmed/30585080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1945892418815615 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|